Evidence map›Paper›PMID 42488126›Full record

ReviewFrontiers in oncology2026

Rosai-Dorfman disease in the breast: a case report and literature review.

Manqing Cao, Liang Deng, Yuanyuan Sun, Yanhui Zhang, Liangsheng Liu, Hong Liu, Tong Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manqing Cao *The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Liang Deng *Department of Breast and Thyroid Surgery, The People's Hospital of the Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China.
Yuanyuan SunDepartment of Breast Pathology and Lab, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
Yanhui ZhangDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
Liangsheng LiuDepartment of Breast Imaging, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Hong LiuThe Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Tong WangThe Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman Disease (RDD) is a rare form of sinus histiocytosis characterized by massive lymphadenopathy, commonly involving lymph nodes and occurring more frequently in children and young adults. Extranodal involvement of the breast is particularly uncommon. Here, we report a rare case of breast RDD, detailing the clinical findings, diagnostic process, and treatment, accompanied by a review of relevant literature. Given the limited cases of breast RDD reported, there is no established consensus on its diagnosis and treatment. This article aims to enhance understanding of breast RDD and inform clinical management practices.

Indexed as

breastextranodal involvementlymph nodesRosai-Dorfman diseasesurgery

Identifiers

PMID42488126
PMCPMC13388065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.